{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-031819","form_type":"8-K","ticker":"NRC","cik":"0000070487","company_name":"NRC HEALTH","filed_at":"2025-10-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:41.943384+00:00","generated_at":"2026-05-17T02:16:00.652494+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"NRC Health Q3 2025: TRCV up 8% to $141.7M; Adj EBITDA +11% YoY to $10.9M","bullets":["Revenue $34.6M (+2% QoQ); GAAP net income $4.1M (12% of revenue); Adj net income $5.0M (14% of revenue).","GAAP EPS $0.18; adjusted EPS $0.23 on 22.1M diluted shares.","Cash from operations $13.8M (+46% YoY), representing 40% of total revenue.","Total Recurring Contract Value (TRCV) $141.7M, up 8% YoY; fourth consecutive quarterly growth.","CEO Trent Green cited strong sales and improved customer retention as growth drivers."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-031819","json":"https://secwatch.observer/filing/0001437749-25-031819.json","markdown":"https://secwatch.observer/filing/0001437749-25-031819.md","text":"https://secwatch.observer/filing/0001437749-25-031819.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/70487/000143774925031819/0001437749-25-031819-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/70487/000143774925031819/nrc20251024_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T02:16:00.652494+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}